Hospitalization – Page 16 – Communicable Diseases Research

Effectiveness of COVID-19 Vaccination on Reduction of Hospitalizations and Deaths in Elderly Patients in Rio Grande do Norte, Brazil

Article

Published on 2022-10-262023-07-10
Journal: International Journal of Environmental Research an [Category] COVID19(2023년),

[키워드] COVID-19 Effectiveness Hospitalization immunization
[DOI] 10.3390/ijerph192113902 PMC 바로가기

Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine

Article

Published on 2022-10-262022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, 치료제,

Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients

Article

Published on 2022-10-262022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제,

[키워드] acting acute respiratory syndrome added Administered administration Amplicon sequencing analyses Analysis antibody Antiviral antiviral property antiviral strategy applied Bacteria benefit Care chills collected Combined coronavirus coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients detectable Diagnosis diarrhea double-blind dried blood spot eligible evaluated Fever Health hospital Hospitalization infected with SARS-CoV-2 Lactobacillaceae lactobacilli Microbiome modulation multifactorial nasopharyngeal viral load nose-throat swab online questionnaire Outpatient Pain Patient per-protocol analysis Placebo placebo-controlled trial positive potential mechanism practitioners qPCR quantitative PCR Randomized reduce reducing reported reported symptom respiratory tract infection respiratory viral disease SARS-CoV-2 selected sequence severity significantly spray strain Symptom symptom resolution the patient the placebo group therapy Throat throat spray. Treatment Trial trials upper respiratory tract Vaccines variant Viral diseases viral infection Viral load was performed
[DOI] 10.1128/spectrum.01682-22 PMC 바로가기

Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study

Article

Published on 2022-10-252022-11-16
Journal: Journal of the Pediatric Infectious Diseases Socie [Category] COVID19(2023년), SARS, 변종,

Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center study

Article

Published on 2022-10-252022-11-16
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome Analysis analyzed Appropriate BMI body mass index cause caused changes in Characteristics city Comorbidities coronavirus coronavirus disease COVID-19 COVID-19 severity cut-off value Dyspnea groups Hospitalization laboratory data LDH management moderate Moderate COVID-19 multiple logistic regression Omicron variant outcome Patient predictor progression renal dysfunction SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants sensitivity severe COVID-19 Sex significant difference significantly single center smoking sore throat specificity Symptoms the disease time Treatment treatment regimens two group university vaccination variant Yokohama
[DOI] 10.1371/journal.pone.0273134 PMC 바로가기

New-onset dermatomyositis following COVID-19: A case report

Article

Published on 2022-10-242022-11-16
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료기술,

[키워드] acute respiratory syndrome addition anti-aminoacyl tRNA synthetase (ARS) antibodies anti-synthetase antibodies antibodies antibody association autoantibody Autoimmune Autoimmune disease Autoimmune diseases biochemical analysis Biological Case report caused Chest clinical feature Clinical features complications Computed tomography contributed coronavirus Coronavirus disease 2019 Corticosteroids cough COVID-19 de novo dermatomyositis dermatomyositis. develop diagnosed diagnostic Dyspnea edema elevations enzyme-linked immunosorbent exacerbate Fever highlight Hospitalization IgG ILD immunoblot infected individual Infectious disease Inflammatory interstitial Interstitial lung disease Japan Japanese lower lobe Lungs male manifestation MOST myalgia myopathies myositis Occurrence organ pathological findings Patient polymerase chain positive Prednisolone presenting profile respiratory symptom SARS-CoV-2 skin rash sore throat Swab syndrome tested transaminases treated tRNA weakness
[DOI] 10.3389/fimmu.2022.1002329 PMC 바로가기

The Possible Impact of Nationwide Vaccination on Outcomes of the COVID-19 Epidemic in North Korea: A Modelling Study

Article

Published on 2022-10-242022-11-16
Journal: Journal of Korean medical science [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome Analysis Asymptomatic B.1.1.529 calibrated compartmental model coronavirus coronavirus disease COVID-19 COVID-19 case COVID-19 transmission COVID-19 vaccination Democratic People's Republic of Korea dose Epidemic epidemiological epidemiological data Epidemiological models exacerbated Hospitalization Impact incidence indicated lack lifted measure National North Omicron variant outcome parameter Prevalence prevalence of COVID-19 projection proportion proportions public health reduced reported Risk assessment Spread suggested suppress suppressed the disease Transmissibility vaccination Vaccine was used
[DOI] 10.3346/jkms.2022.37.e300 PMC 바로가기

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile

Article

Published on 2022-10-212022-11-16
Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종,

Effectiveness of COVID-19 vaccination in healthcare workers in Shiga Prefecture, Japan

Article

Published on 2022-10-212022-11-15
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 진단,

Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana

Article

Published on 2022-10-212022-11-16
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종,

[키워드] Admission age analyzed B.1.1.529 Characteristics clinical Clinical outcome cohort analysis Comorbidity contributed COVID-19 pandemic defined determine diagnoses Diagnosis discharge disease severity Factor Features Fewer patient FIVE higher risk hospital Hospitalization hospitalized patient ICU ICU admission Infection less Mortality omicron one way ANOVA outcome outcomes overall mortality Patient peer positive presenting presenting symptom progressed proportion Protective required risk SARS-CoV-2 SARS-CoV-2 test severe disease Sex subsequent subset Symptom the SARS-CoV-2 the United State vaccination variant Ventilation was performed
[DOI] 10.1371/journal.pone.0268853 PMC 바로가기